FDA Clears Hologic’s Molecular GI Pathogen Tests
New assays detect common bacterial causes of infectious gastroenteritis using molecular technology on existing diagnostic platforms.
New assays detect common bacterial causes of infectious gastroenteritis using molecular technology on existing diagnostic platforms.
Castle Biosciences' Barrett’s Esophagus test delivered over 25,000 reports to support risk assessment for Barrett’s Esophagus patients.
Lucid Diagnostics celebrates testing the 4,000th firefighter for esophageal precancer using the EsoGuard Esophageal DNA test.
Researchers have shown that changes can be detected in blood tests up to eight years before a diagnosis of Crohn’s disease.
Read MoreLaboratory services company PathAI Diagnostics unveiled an AI-assisted LDT for the histologic scoring and staging of MASLD and MASH.Â
Read MoreCOVID-19 has reshaped the global landscape of gastrointestinal infections, notably surging norovirus cases. Coupled with an increasing immunity gap due to reduced vaccinations, healthcare systems are on alert. Seegene offers solutions for these unprecedented challenges.
Read MoreIn an era of rapid technological advancements, the traditional art of morphological diagnosis in parasitology remains crucial. This piece delves into the juxtaposition of modern methods and foundational expertise, emphasizing the need for a harmonious integration in the face of emerging parasitic threats.
Read MoreThe U.S. FDA cleared the chromogranin A test and immunoassay for the assessment of tumor progression in GEP-NET patients.
Read MoreHospital-onset infections still occur—the most common caused by C. diff, the culprit in almost half a million infections yearly in the U.S.
Read MoreCairn Diagnostics’ 13C-Spirulina Gastric Emptying Breath Test was included in ACG Clinical Guidelines for the diagnosis of gastroparesis.
Read MoreDelve into the transformative role of AI in parasitology diagnostics. The research highlights the potential of convolutional neural networks (CNN) in detecting intestinal protozoa, offering insights into improved accuracy and the broader implications for lab professionals. A must-read for those at the intersection of technology and medical diagnostics.
Read MoreDiagnostic tests for an H. pylori infection can be invasive or noninvasive. Noninvasive testing is more cost-effective.
Read MoreLearn about dependable noninvasive H. pylori diagnostic testing solutions, like the BreathID®...
Read MoreCastle Biosciences’ Barrett’s Esophagus test can improve management decisions for Barrett’s esophagus patients with low-grade dysplasia.
Read MoreThe U.S. FDA has approved QIAGEN’s therascreen PDGFRA kit, which is a companion diagnostic for the gastrointestinal cancer drug Ayvakit.
Read MoreCDx Diagnostics reported positive data of the WATS3D AI Platform for the detection and surveillance of Barrett’s esophagus (BE) and dysplasia.
Read MoreEmbark on a journey through our comprehensive analysis of the fading presence of diagnostic morphological parasitologists. Grasp the global health implications and the pressing call for a harmonized approach in parasitology.
Read MoreIn the dynamic field of medical technology, the future of diagnostic parasitology is being...
Read More